Potential asthma management via yeastPerinatal administration of Saccharomyces cerevisiae UFMG A-905 prevents asthma development in the offspring of mice.
We explored how perinatal administration of Saccharomyces cerevisiae UFMG A-905 could help prevent asthma in mouse offspring. This study involved various groups of mice receiving the yeast at different stages: before conception, during pregnancy, or only during lactation.
Our results showed that those exposed to S. cerevisiae exhibited significantly less airway hyperresponsiveness and lower levels of certain inflammatory markers compared to those that didn’t receive the treatment. Notably, the greatest protection occurred when the yeast was given during lactation.
Overall, it seems that S. cerevisiae UFMG A-905 shows promise in the management of asthma, especially when administered early in the offspring's development.
Read More
EpiCor reduces cold/flu symptomsEfficacy of a yeast postbiotic on cold/flu symptoms in healthy children: A randomized-controlled trial.
We investigated how EpiCor, a yeast-derived postbiotic, influences cold and flu symptoms in children aged 4-12. Two hundred fifty-six kids participated in a randomized, controlled trial over 84 days during the flu season.
Those receiving EpiCor showed significantly less symptom severity and reduced use of cold medications compared to the placebo group.
This suggests EpiCor is a promising option to boost immune function and reduce illness in school-aged children without undesirable side effects.
Read More
UFMG A-905 bread and asthmaA Functional Bread Fermented with UFMG A-905 Prevents Allergic Asthma in Mice.
We aimed to examine whether bread fermented with UFMG A-905 could help prevent allergic asthma. In our study, we created three types of bread and tested them on mice sensitized to allergens.
The results showed that the UFMG A-905 fermented bread could significantly reduce some asthma-like symptoms, particularly when paired with microcapsules containing live yeast.
Overall, this suggests that incorporating UFMG A-905 into food could be a promising approach for managing allergies.
Read More
Maitake mushrooms may alleviate allergies extract and ergosterol reduce allergic reactions in an allergy mouse model by suppressing the degranulation of mast cells.
We explored the potential of maitake mushroom extracts in combating allergies, focusing on their effects on mast cells, which play a key role in allergic reactions. Our study specifically examined the impact of the mushroom extract, GFE, and its active component, ergosterol, on allergic responses in a mouse model.
Through a well-structured air pouch-type allergic inflammation model, we observed that both GFE and ergosterol significantly inhibited the degranulation of mast cells. This is a critical process where mast cells release compounds that cause allergic symptoms.
Notably, our findings revealed that GFE and ergosterol effectively alleviated anaphylactic responses in these mice. This suggests that maitake mushrooms could offer a promising, natural approach to reducing allergic reactions by targeting mast cell degranulation, making it a potential novel functional food for allergy prevention.
Read More